Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Readministration of adenoviral gene delivery to dopamine neurons.

Gonzalez SC, McMenamin MM, Charlton HM, Goodman J, Lantos T, Simpson C, Wood MJ.

Neuroreport. 2007 Oct 8;18(15):1609-14.

PMID:
17885611
[PubMed - indexed for MEDLINE]
2.

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang YN, Chiang YL, Qian J, Bardwaj L, Bohn MC.

Exp Neurol. 1998 Dec;154(2):261-75.

PMID:
9878166
[PubMed - indexed for MEDLINE]
3.

In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system.

Torres EM, Monville C, Lowenstein PR, Castro MG, Dunnett SB.

Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):1-10. Epub 2005 Apr 18.

PMID:
15950755
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Optimization of adenoviral vector-mediated gene transfer to pulmonary arteries in newborn swine.

Badran S, Schachtner SK, Baldwin HS, Rome JJ.

Hum Gene Ther. 2000 May 20;11(8):1113-21.

PMID:
10834614
[PubMed - indexed for MEDLINE]
5.

Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies.

Tominaga K, Kuriyama S, Yoshiji H, Deguchi A, Kita Y, Funakoshi F, Masaki T, Kurokohchi K, Uchida N, Tsujimoto T, Fukui H.

Gut. 2004 Aug;53(8):1167-73.

PMID:
15247187
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Expression of the lacZ reporter gene in the rat basal forebrain, hippocampus, and nigrostriatal pathway using a nonreplicating herpes simplex vector.

Maidment NT, Tan AM, Bloom DC, Anton B, Feldman LT, Stevens JG.

Exp Neurol. 1996 May;139(1):107-14.

PMID:
8635556
[PubMed - indexed for MEDLINE]
7.

Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.

Van Linthout S, Lusky M, Collen D, De Geest B.

Gene Ther. 2002 Nov;9(22):1520-8.

PMID:
12407424
[PubMed - indexed for MEDLINE]
Free Article
8.
9.

Immunomodulation with FK506 around the time of intravenous re-administration of an adenoviral vector facilitates gene transfer into primed rat liver.

Kuriyama S, Tominaga K, Mitoro A, Tsujinoue H, Nakatani T, Yamazaki M, Nagao S, Toyokawa Y, Okamoto S, Fukui H.

Int J Cancer. 2000 Mar 15;85(6):839-44.

PMID:
10709105
[PubMed - indexed for MEDLINE]
10.
11.

Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.

Everett RS, Hodges BL, Ding EY, Xu F, Serra D, Amalfitano A.

Hum Gene Ther. 2003 Dec 10;14(18):1715-26.

PMID:
14670123
[PubMed - indexed for MEDLINE]
12.

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.

Björklund A, Kirik D, Rosenblad C, Georgievska B, Lundberg C, Mandel RJ.

Brain Res. 2000 Dec 15;886(1-2):82-98. Review.

PMID:
11119690
[PubMed - indexed for MEDLINE]
13.

[Monitoring retrograde adenoviral transgene expression in spinal cord and anterograde labeling of the peripheral nerves].

Han J, Zhang Y, Chen W, Song C.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005 Mar 15;19(3):215-20. Chinese.

PMID:
15828479
[PubMed - indexed for MEDLINE]
14.

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.

Morral N, O'Neal W, Rice K, Leland M, Kaplan J, Piedra PA, Zhou H, Parks RJ, Velji R, Aguilar-Córdova E, Wadsworth S, Graham FL, Kochanek S, Carey KD, Beaudet AL.

Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12816-21.

PMID:
10536005
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequences.

Franklin Rm, Quick Mm, Haase G.

Gene Ther. 1999 Aug;6(8):1360-7.

PMID:
10467360
[PubMed - indexed for MEDLINE]
17.

Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.

Scarpini CG, May J, Lachmann RH, Preston CM, Dunnett SB, Torres EM, Efstathiou S.

Gene Ther. 2001 Jul;8(14):1057-71.

PMID:
11526453
[PubMed - indexed for MEDLINE]
Free Article
18.

Adenoviral vector-mediated gene delivery to injured rat peripheral nerve.

Dijkhuizen PA, Pasterkamp RJ, Hermens WT, de Winter F, Giger RJ, Verhaagen J.

J Neurotrauma. 1998 Jun;15(6):387-97.

PMID:
9624624
[PubMed - indexed for MEDLINE]
19.

Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.

Lewis TB, Glasgow JN, Glandon AM, Curiel DT, Standaert DG.

PLoS One. 2010 Sep 17;5(9). pii: e12672. doi: 10.1371/journal.pone.0012672.

PMID:
20862245
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A high-efficiency synthetic promoter that drives transgene expression selectively in noradrenergic neurons.

Hwang DY, Carlezon WA Jr, Isacson O, Kim KS.

Hum Gene Ther. 2001 Sep 20;12(14):1731-40.

PMID:
11560767
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk